A. Gulías-Herrero

Effect of imatinib on plasma glucose concentration in subjects with chronic myeloid leukemia and gastrointestinal stromal tumor

F. Gómez-Pérez, A. Zentella-Dehesa, D. Cuevas-Ramos, 2018, BMC Endocrine Disorders.

Comparison of Adiposity Indices and their Association with Insulin Resistance and β-Cell Dysfunction in Primary Prevention for Diabetes in Mexican Population

C. Meza-Arana, A. Gulias-Herrero, M. Gómez-Sámano, 2022, Diabetes Epidemiology and Management.

Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open-label study.

C. Aguilar-Salinas, E. Meaney, R. Moguel, 2000, Atherosclerosis.

Outcomes and Challenges of Reproductive Health in Hematopoietic Stem Cell Transplantation Survivors.

A. Gulias-Herrero, M. Bourlon, C. Bourlon, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Oncofertility Knowledge Among Internal Medicine Residents in an Academic Center in Mexico

A. Gulias-Herrero, M. Bourlon, H. Verduzco-Aguirre, 2020, Journal of Cancer Education.

Oncofertility Knowledge Among Internal Medicine Residents in an Academic Center in Mexico

A. Gulias-Herrero, M. Bourlon, H. Verduzco-Aguirre, 2020, Journal of Cancer Education.

Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City

D. Kershenobich-Stalnikowitz, J. Sifuentes-Osornio, J. Dorantes-García, 2021, Frontiers in Pharmacology.

Metformin and improvement of the hepatic insulin resistance index independent of anthropometric changes.

R. Mehta, D. Cuevas-Ramos, María Vázquez-Hernández, 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.